The Microbiome Industry Year in Review with Adrien Nivoliez: The LBP manufacturing perspective
The regulatory environment for live biotherapeutic products is still uncertain globally, of course, but one booming area is the manufacturing of these products as they move through their clinical development process. Adrien Nivoliez, CEO of Biose Industrie reflects on […]